Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,725,321,575
-$3,042,044 QoQ
Shares Held
6,793,407
-3.9% QoQ
Ownership
0.282%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#41
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swiss National Bank holds $9,526,453,117 across 11 Drug Manufacturers - General names. JNJ ranks #2 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,265,150 | $2,716,889,091 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
6,793,407 | $1,725,321,575 | |
| 3 | ABBV |
AbbVie Inc.
|
4,988,710 | $1,255,358,984 | |
| 4 | AZN |
Astrazeneca PLC
|
5,934,315 | $1,125,264,810 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,973,251 | $896,062,753 | |
| 6 | AMGN |
Amgen Inc
|
1,520,393 | $550,564,713 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,500,700 | $442,278,438 | |
| 8 | PFE |
Pfizer Inc
|
16,043,812 | $386,334,992 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,725,321,575 | 6,793,407 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,728,363,619 | 7,070,707 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,365,788,668 | 6,599,607 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,286,018,791 | 6,935,707 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,114,281,769 | 7,294,807 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,126,170,848 | 6,790,707 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $983,460,398 | 6,800,307 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,157,709,156 | 7,143,707 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,042,823,391 | 7,134,807 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,140,424,455 | 7,209,207 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,180,206,275 | 7,529,707 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,206,206,965 | 7,744,507 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,553,322,440 | 9,384,500 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,608,249,000 | 10,375,800 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,887,628,905 | 10,685,700 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,862,927,381 | 11,403,816 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,024,575,394 | 11,405,416 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,020,867,910 | 11,402,516 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,711,729,157 | 10,006,016 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,681,653,634 | 10,412,716 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,765,801,273 | 10,718,716 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,814,155,452 | 11,038,366 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,707,001,081 | 10,846,366 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $1,658,488,362 | 11,139,766 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,589,803,305 | 11,304,866 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,461,806,555 | 11,147,766 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||